Dextofisopam
Dextofisopam is the R-enantiomer of the homophthalazine tofisopam. Dextofisopam can be studied in research on irritable bowel syndrome and inflammatory bowel disease[1].
Product Specifications
CAS Number
82059-50-5
UNSPSC
12352005
Target
Biochemical Assay Reagents
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
CC1=NN=C(C2=CC=C(OC)C(OC)=C2)C3=CC(OC)=C(OC)C=C3[C@H]1CC
Molecular Formula
C22H26N2O4
Molecular Weight
382.45
References & Citations
[1]Leventer, Steven M., et al., THE POTENTIAL OF DEXTOFISOPAM FOR TREATMENT OF IRRITABLE BOWEL SYNDROME AND INFLAMMATORY BOWEL DISEASE. American Journal of Gastroenterology 99 () :p S279, October 2004.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
